Allergy Therapeutics plc

Allergy Therapeutics plcverified

AGYTF

Price:

$0.11

Market Cap:

$496.27M

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-02-03

Stock Exchange

OTC

Ticker

AGYTF

The Enterprise Value as of December 2025 (TTM) for Allergy Therapeutics plc (AGYTF) is 519.12M

According to Allergy Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 519.12M. This represents a change of 235.21% compared to the average of 154.86M of the last 4 quarters.

Allergy Therapeutics plc (AGYTF) Historical Enterprise Value (quarterly & annually)

How has AGYTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Allergy Therapeutics plc over the last ten years is 10.31B. The current 519.12M Enterprise Value has changed 403.57% with respect to the historical average. Over the past ten years (40 quarters), AGYTF's Enterprise Value was at its highest in in the December 2021 quarter at 22.15B. The Enterprise Value was at its lowest in in the June 2006 quarter at 4.86M.

Quarterly (TTM)
Annual

Average

10.31B

Median

11.20B

Minimum

28.18M

Maximum

16.75B

Allergy Therapeutics plc (AGYTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Allergy Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 588.53%

Maximum Annual Enterprise Value = 16.75B

Minimum Annual Increase = -99.79%

Minimum Annual Enterprise Value = 28.18M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024194.01M588.53%
202328.18M-99.79%
202213.33B-20.42%
202116.75B78.63%
20209.38B2.59%
20199.14B-45.38%
201816.74B10.67%
201715.12B43.54%
201610.54B-11.12%
201511.86B70.71%

Allergy Therapeutics plc (AGYTF) Average Enterprise Value

How has AGYTF Enterprise Value performed in the past?

The current Enterprise Value of Allergy Therapeutics plc (AGYTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.52B

5-year avg

7.94B

10-year avg

10.31B

Allergy Therapeutics plc (AGYTF) Enterprise Value vs. Peers

How is AGYTF’s Enterprise Value compared to its peers?

Allergy Therapeutics plc’s Enterprise Value is greater than Verano Holdings Corp. (347.99M), less than Glass House Brands Inc. (523.31M), greater than ManifestSeven Holdings Corporation (22.25M), less than Cresco Labs Inc. (785.93M), greater than Boiron S.A. (489.54M), less than JCR Pharmaceuticals Co., Ltd. (114.39B), less than MedinCell S.A. (859.57M), less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (13.51B), less than Hua Medicine (Shanghai) Ltd. (2.16B), greater than Lattice Biologics Ltd. (3.09M),

Build a custom stock screener for Allergy Therapeutics plc (AGYTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allergy Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allergy Therapeutics plc (AGYTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allergy Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Allergy Therapeutics plc's Enterprise Value?

What is the highest Enterprise Value for Allergy Therapeutics plc (AGYTF)?

What is the 3-year average Enterprise Value for Allergy Therapeutics plc (AGYTF)?

What is the 5-year average Enterprise Value for Allergy Therapeutics plc (AGYTF)?

How does the current Enterprise Value for Allergy Therapeutics plc (AGYTF) compare to its historical average?